On March 19, 2020, the FDA issued an update regarding the risk of EDKA development after surgery in patients on SGLT2i
The four-pathway model therefore targets appetite (GLP-1 and amylin through separate neuronal circuits), fat metabolism (GIP and glucagon), energy expenditure (glucagon primarily), and glucose homeostasis (GLP-1, GIP, and amylin all contribute through different mechanisms)
This litigation would give many people a new legal option if they were diagnosed with NAION after taking Wegovy
In practice a GP or nurse may administer off-licence by giving a sub-cutaneous (under the skin, SC) injection but it is important to remember that the GP makes their own decision and takes their own accountability and reliability if they go off-licence
See Whether You Qualify for GLP-1 Treatment Complete a 5-minute intake so a licensed provider can review your health history, weight goals, and whether GLP-1 treatment may be appropriate